JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2010, Vol. 48 ›› Issue (6): 115-.

• Articles • Previous Articles     Next Articles

Significance of  determination of telomerase activity in induced sputum and fiberobronchoscopic biopsy samples for lung cancer diagnosis

LI Hongmei1, FENG Rui2, WANG Zixuan3, XIN Luqun1   

  1. 1. Cancer Center,  Affiliated Hospital of Medical College, Qingdao University, Qingdao 266003, Shandong, China;
    2. Department of Hematology,  Affiliated Hospital of Binzhou Medical College, Binzhou 256600, Shandong, China;
    3. Department of Intervention,Qingdao Municipal Hospital, Qingdao 266011, Shandong, China
  • Received:2009-12-14 Online:2010-06-16 Published:2010-06-16

Abstract:

Objective  To investigate the significance of  determination of telomerase activity in induced sputum and fiberobronchoscopic biopsy samples in lung cancer patients. Methods  The technique of TRAP(telomeric repeat amplification protocal)-PCR-ELISA was employed to detect telomerase levels in induced sputum and fiberobronchoscopic biopsy samples in 80 lung cancer patients and  50  benign lung disease patients. Results  Telomerase levels in induced sputum and fiberobronchoscopic biopsy  samples were higher in patients with lung cancer than in those with benign lung disease(P<0.001).There was no significant difference in telomerase activity between the different pathologic types(P>0.05).The sensitivity, specificity and overall accuracy of telomerase activity was  62.5% (50/80), 72.0 % (36/50) and 66.2%(86/130) in induced sputum, and 60.0%(48/80), 70.0%(35/50), and 63.8%(83/130) in  fiberobronchoscopic biopsy sample respectively. The sensitivity, specificity and overall accuracy of telomerase activity determined by the above methods simultaneously as 82.5%(66/80), 64.0%(32/50)and 75.4%(98/130) respectively. Conclusion  Determination of telomerase activity in induced sputum and fiberobronchoscopic biopsy samples has higher sensitivity and can improve the diagnostic accuracy for lung cancer.

Key words: Telomerase; Sputum; Bronchoscopes; Lung neoplasms; Diagnosis

CLC Number: 

  • R734.2
[1] XU Xiao-ya, BI Yu-li, JIANG Man, XU Ji-ying, ZHANG Peng-fei, HAN Ming-yong. Vascular endothelial growth factor (VEGF) promotes lung carcinoma metastasis via VEGFR1 in mouse model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 25-29.
[2] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 108-110.
[3] TIAN Tian-tian1, LI Ji-sheng1, WANG Ya-wei1, MA Dao-xin2, WANG Xiu-wen1. Genistein exerts antitumor effects in small cell lung cancer H446 cells via suppressing the activity of FoxM1 pathway [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(06): 44-48.
[4] LIU Bing1, YU Zhuang1, HOU Xian-peng1, YAO Ru-yong2. Different expressions of EGFR and HER-3 genes in human lung adenocarcinoma cells and pemetrexed-resistant cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 20-23.
[5] ALIMUJIANG·Stiwaerdi, ZHANG Tao, PATIGULI·Aerxiding, LIU Li. Clinical analysis of recombinant human endostatin combined with gemcitabine and  cisplatin therapy in advanced non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 95-98.
[6] DONG Xue-li, MU Xiao-yan, LIU Qing-liang, SUN Jie. Effects of erlotinib combined with celecoxib on growth and angiogenesis of human lung cancer xenograft model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 49-52.
[7] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(10): 130-131.
[8] LIU Qing-liang1, MU Xiao-yan1, WANG-Jing2, CHI Xiang-yu2, ZHANG Min3, MA Wei-xia3. Inhibitory effects of RNA interference and Erlotinib by blocking epidermal
growth factor receptor pathway on the proliferation of A549 cells
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 11-.
[9] FAN Heng-jian, ZHANG Yu-ke, XIAO Wei, ZHANG Yi, LI Hai-jun, WANG De-xiang. Changes of Treg and Th17 cells in the peripheral bloods of patients with
lung adenocarcinoma and their prognostic significance
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 73-78.
[10] WANG Ji-xia, LI Gui-xin, HUANG Yan, WANG Li-juan. Expressions and clinical significances of E1AF,MMP-7 and uPA in nonsmall cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 109-.
[11] XU Tong-zhen, SUN Xue-fei, REN Dong-mei, YANG Guo-tao. Antiproliferation activity of luteolin and its role in combined chemotherapy on lung cancer A549 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 50-54.
[12] LIU Hai-rong1, YU Jin-ming2, LI Yan1, LIANG Jing1, LIU Xiao-lin1. Study of the relationship between ER, PR, C-erB-2 and
bone metastasis of  lung adenocacinoma
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(4): 91-.
[13] MA Yu-hua1,2, ZHENG Yan3, JIA Yan-fei3, WANG Yun-shan3. GFR and DEC1 protein co-expression promotes lymph node
metastasis in lung adenocarcinoma
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 24-28.
[14] SUN Xue-fei, PEI Yan-tao,YIN Qiu-wei, YANG Guo-tao, WANG De-jiang. Inhibitory effect of Radix Actinidiae extractive on transplantation
tumor of the lung cancer cell line A549 in nude mice
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 38-42.
[15] LI Peng, LIU Qi, HAN Ming-yong. PET/CT,CEA and CYFRA21-1 predicting the therapeutic effect of targeted drug on non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(1): 129-132.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!